Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverCXXIF
HealthcareOQXUSD

C21 Investments Inc.

$00123456789.00123456789001234567890.0%
52w low $0.17$0.54 52w high
Market data · last updated 1d ago
Market data
Market cap
$25.28M
52w range
$0.17 - $0.54
Beta
1.89
Sector
Healthcare
Data quality
83/100
Valuation
fair value estimate
$0.22
Margin of safety
-17.0%
Quality & efficiency
Moat score
23/100
Return on equity
-12.0%
Profit margin
-9.9%
Debt / equity
0.41
Growth & analysts
Revenue growth
-8.1%
Run the 10-point checklist before you buy How these numbers are made

About C21 Investments Inc.

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company offers its products through wholesale and retail channels. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada. As of August 21, 2026, C21 Investments Inc. operates as a subsidiary of Vireo Growth Inc.

Valuation

ValueGrowthProfitHealthIncome26QUALITY
Overall Rating
32
Low quality
Low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score23
Fair value estimate
$0.22-17.0% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$25.28M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
-8.1%
Profit Margin
-9.9%
ROE
-12.0%
Debt / Equity
0.41
Beta
1.89
Beaten Down

Statistics

Similar Stocks · Healthcare

Latest News · CXXIF